Navigation Links
Bayer's Investigational Riociguat Granted U.S. FDA Priority Review for Pulmonary Arterial Hypertension and Inoperable or Persistent/Recurrent Chronic Thromboembolic Pulmonary Hypertension
Date:4/7/2013

l was improvement in 6-minute walking distance. The riociguat dose was titrated, over a period of eight weeks in doses of 0.5 mg increments from 1.0 mg up to 2.5 mg three times daily. Patients were then followed for an additional four weeks to complete the study. Patients then had the option of participating in the open label extension study, after completing an eight-week blinded sham titration.

About Riociguat
Riociguat (BAY 63-2521), discovered and developed at the Bayer research laboratories, is an investigational oral soluble guanylate cyclase (sGC) stimulator that is being studied in CTEPH and PAH, as well as other forms of pulmonary hypertension. Riociguat is an investigational agent and is not approved by the FDA, EMA or other health authorities.

About Bayer HealthCare Pharmaceuticals Inc.
Bayer HealthCare Pharmaceuticals Inc. is the U.S.-based pharmaceuticals business of Bayer HealthCare LLC, a subsidiary of Bayer AG. Bayer HealthCare is one of the world's leading, innovative companies in the healthcare and medical products industry, and combines the activities of the Animal Health, Consumer Care, Medical Care, and Pharmaceuticals divisions. As a specialty pharmaceutical company, Bayer HealthCare provides products for General Medicine, Hematology, Neurology, Oncology and Women's Healthcare. The company's aim is to discover and manufacture products that will improve human health worldwide by diagnosing, preventing and treating diseases.

Bayer® and the Bayer Cross® are registered trademarks of Bayer.

Forward-Looking Statement
This news release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given
'/>"/>

SOURCE Bayer HealthCare
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Positive Preclinical Data for NKTR-214, an Investigational Cancer Immunotherapy Targeting the IL-2 Receptor Complex, Presented at AACR Annual Meeting 2013
2. European Medicines Agency accepts marketing authorization application for Boehringer Ingelheim and Eli Lilly and Companys empagliflozin*, an investigational type 2 diabetes treatment
3. Boehringer Ingelheim and Eli Lilly and Company submit new drug application to FDA for empagliflozin, an investigational type 2 diabetes treatment
4. Genocea Publishes Preclinical Data For Investigational Vaccine Candidate For HSV-2
5. Noven Announces FDA Advisory Committee Vote on Investigational Low-Dose Mesylate Salt of Paroxetine (LDMP) for Vasomotor Symptoms Associated with Menopause
6. Scioderms Investigational New Drug (IND) Application for SD-101 for Treatment of Epidermolysis Bullosa (EB) Allowed by the FDA
7. BHR Pharma Investigational Traumatic Brain Injury Treatment Receives European Medicines Agency Orphan Medicinal Product Designation
8. Follow-up Results of Phase 2 Study of Investigational Agent, Ibrutinib, in Relapsed/Refractory Mantle Cell Lymphoma Presented at American Society of Hematology Annual Meeting
9. Follow-up Results of Phase 2 Study of Investigational Agent, Ibrutinib, Suggest High and Durable Responses in Relapsed/Refractory Mantle Cell Lymphoma
10. FDA Accepts Novens NDA For An Investigational Nonhormonal Therapy For Menopausal Vasomotor Symptoms
11. Healthpoint Biotherapeutics Initiates Phase III Study of Unique Investigational Cell-Based Therapy for Venous Leg Ulcers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... Aug. 21, 2014 Nektar Therapeutics (NASDAQ: ... today announced positive results from its Phase 3 ... extended half-life recombinant factor VIII (rFVIII) treatment for ... which met its primary endpoint in reducing annualized ... to the on-demand arm. Top-line results ...
(Date:8/21/2014)... Canadian Epilepsy Alliance (CEA) is thrilled to announce the launch ... the most common neurological disorder in Canada ... tells a fictional story based on the experiences of 14-year-old ... "Despite the fact that epilepsy affects 1 ... lack of awareness out there," says Gail Dempsey , ...
(Date:8/21/2014)... percent of Americans believe the abuse of strong prescription pain ... safety issue in the United States , ... & Partners, a Cincinnati based research ... the prescription medication abuse problem and the need for medical ... facing our country," Rex Repass , CEO of the ...
Breaking Medicine Technology:Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 2Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 3Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 4Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 5Action Heroes Harness Powers to Educate Children About Epilepsy 2Action Heroes Harness Powers to Educate Children About Epilepsy 3Consumers Desperate For Measures To Curb Prescription Drug Abuse 2Consumers Desperate For Measures To Curb Prescription Drug Abuse 3
... 2011 ORTHOCON, Inc., a privately-held therapeutic device ... worldwide license agreement with Bezwada Biomedical to develop ... Bezwada Biomedical is an innovation-driven company ... biocompatible polyurethanes and polyamides derived from hydrolyzable isocyanates. ...
... Caliper Life Sciences, Inc. (NASDAQ: CALP ... Spectrum CT , a breakthrough preclinical imaging system that ... and low dose microCT (micro computed tomography).  Spectrum CT ... with vital, unparalleled insights into complex biological systems in ...
Cached Medicine Technology:ORTHOCON Announces Signing of Exclusive, Worldwide License Agreement With Bezwada Biomedical 2Caliper Life Sciences Announces IVIS Spectrum CT 2Caliper Life Sciences Announces IVIS Spectrum CT 3
(Date:8/22/2014)... Yountville, CA (PRWEB) August 22, 2014 Tug ... White and Blue (Team RWB) to participate in the 39th ... athletes and Team McGraw runners will join forces in coaching, ... the most significant highlights of our nation's capital and is ... Begun in 1975, the Marine Corps Marathon is the largest ...
(Date:8/22/2014)... California (PRWEB) August 22, 2014 The ... , BillionaireFish.com, recently registered its two millionth member, and ... threshold. , Billionairefish.com is a dating website for ... women to date. The dating website caters like-minded people ... dating site for the rich , this is ...
(Date:8/22/2014)... 22, 2014 The Berkowitz Law Firm ... a client who suffered severe, permanent injuries in an ... driver (docket number FST-CV13-6018309-S). The case was pending in ... According to Jennifer Amdur of The Berkowitz Law Firm ... all of whom were allegedly injured following ...
(Date:8/22/2014)... Reacting to naysayers who are being skeptical about ... top PRP therapy LA specialist has firmly stated that ... with practical well researched science and nothing to do ... new medical breakthrough technology which focuses on healing and ... therapy. , The Managing Director of one of the ...
(Date:8/22/2014)... 2014 The rising numbers of teen drug ... in Asheville, NC. For many years, countless lives have been ... difference in the community a new helpline was established to ... in North Carolina who are seeking to overcome their addiction ... at (828) 348-5762, parents and their teens can speak immediately ...
Breaking Medicine News(10 mins):Health News:Tug McGraw Foundation and Team Red White and Blue Join to Run in Marine Corps Marathon 2Health News:Tug McGraw Foundation and Team Red White and Blue Join to Run in Marine Corps Marathon 3Health News:Rich Men & Women Dating Site Billionairefish.com Exceeds Two Million Members 2Health News:Rich Men & Women Dating Site Billionairefish.com Exceeds Two Million Members 3Health News:The Berkowitz Law Firm LLC Reaches a $2 Million Settlement for a Client Allegedly Injured in Drunk Driving Accident 2Health News:MetroMD With The Help Of PRP Therapy Helps People Fight Hip Injuries 2Health News:Troubled Teens in Asheville, NC Turn to Helpline for Valuable Assistance 2
... Bertalan Mesko, medical blogger and health 2.0 consultant, ... medical and scientific videos and animations. This list ... best quality. Some of the sites are created for ... focusing on health issues, while others were designed primarily ...
... who,d been tormented, , , FRIDAY, May 8 (HealthDay News) ... younger are more likely than others their age to ... report. , Their study involved 6,437 youths, who averaged ... provided regular updates about the youngsters, health and development ...
... CDC report shows 11 cases of similar strain since 2005 ... puzzled as to the roots of the swine flu outbreak currently ... U.S. Centers for Disease Control and Prevention and released online Thursday ... 11 cases of infection with a swine flu virus similar to ...
... May 8 The majority of uninsured American families ... an employer cannot afford to buy health insurance, according ... Research and Quality.Some experts have suggested that because 23.8 ... have access to employer-based health insurance have incomes above ...
... WINNIPEG, May 8 /PRNewswire/ - Kevin McGarry, Chairman of ... Systems), announces the appointment of Dr. Niels Erik Hansen ... to the appointment of Dr Hansen, Mr. McGarry held ... Chief Executive Officer and stewarded its evolution from a ...
... Pregnancy (MiP) Consortium, led by the Liverpool School of ... European and Developing Countries Clinical Trials Partnership (EDCTP) to ... The three grant recipients the Liverpool School ... Research in Spain and the Prince Leopold Institute of ...
Cached Medicine News:Health News:Bullying Seems to Affect Kids Years Later 2Health News:Scientists Still Baffled About Origins of Swine Flu 2Health News:Scientists Still Baffled About Origins of Swine Flu 3Health News:Scientists Still Baffled About Origins of Swine Flu 4Health News:New Study Finds Fewer Families Can Afford Health Insurance 2Health News:MiP Consortium awarded €11 million by EDCTP 2Health News:MiP Consortium awarded €11 million by EDCTP 3
... broad selection of tip styles for ... ophthalmic procedures. Each single use cautery ... safety cap to lock switch in ... in use, and carries a 3-4 ...
... Accu-Temp Cauteries provide a broad ... in a wide variety of ophthalmic ... packaged sterile, complete with a safety ... "off " position when not in ...
... Probes provide the surgeon with an indirect ... to be easily visualized through the laser ... and light scatter technique, the surgeon can ... flap edge folds, corneal flap striae and ...
... The B-VAT® PC visual acuity system allows ... of the B-VAT II. The system includes ... contrast sensitivity testing and animated characters. Random ... operator has single letter, single line and ...
Medicine Products: